Laser discectomy and radiofrequency coblation (disc nucleoplasty)
Defines Blue Cross Blue Shield Massachusetts coverage position for laser discectomy and radiofrequency coblation (disc nucleoplasty) for commercial and Medicare members, including authorization requirements, coding considered investigational, and clinical evidence summary.
Annual policy review updated literature through February 23, 2026; references added. Policy statements unchanged.
Clarified coding information.
Coverage Summary
Scope: This policy defines Blue Cross Blue Shield Massachusetts coverage position for laser discectomy and radiofrequency coblation (disc nucleoplasty) for commercial and Medicare members, including authorization requirements, coding considered investigational, and a clinical evidence summary. Background: Laser discectomy and radiofrequency coblation (disc nucleoplasty) are minimally invasive procedures evaluated for decompression of the intervertebral disc to treat discogenic back pain and radiculopathy. The evidence from randomized trials, systematic reviews, and observational studies is insufficient to demonstrate an improved net health outcome. For services described in this policy, precertification/preauthorization is required if the procedure is performed inpatient. The policy status is Investigational.